About
- Name
- Hwabao WP Hang Seng SCHK Innovative Drug Select ETF
- Index tracked
- Hang Seng SCHK Innovative DrugSel PR CNY
- Type
- Equity
- Expense ratio
- --
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 0.4515 (09/13/2026)
- Issued units
- 5.73B (06/30/2026)
- Listing date
- Jun 27, 2025
- Sponsor
- Hwabao WP Fund Management Co.,Ltd
- Custodian
- Guosen Securities Co Ltd
ETF Documents
Last updatedType
08/31/2026Semi Annual Report
03/31/2026Annual Report
11/19/2025Prospectus
07/21/2026Quarterly Report